Oncolys BioPharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 845,800 | 3.41% |
Individual Insiders | 981,200 | 3.95% |
Institutions | 1,657,746 | 6.68% |
General Public | 21,338,116 | 86% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
890,600 | JP¥578.0m | 0% | 0.26% | |||
727,200 | JP¥472.0m | 0% | no data | |||
696,200 | JP¥451.8m | 0% | 1.37% | |||
551,114 | JP¥357.7m | 0% | 0.12% | |||
498,900 | JP¥323.8m | 0% | no data | |||
405,000 | JP¥262.8m | -9.19% | 1.92% | |||
219,000 | JP¥142.1m | 0% | no data | |||
205,400 | JP¥133.3m | 0% | 0.02% | |||
128,700 | JP¥83.5m | 0% | no data | |||
118,600 | JP¥77.0m | 0% | no data | |||
115,000 | JP¥74.6m | 0% | no data | |||
109,100 | JP¥70.8m | 1.39% | 0.05% | |||
100,500 | JP¥65.2m | 0% | 0.33% | |||
100,000 | JP¥64.9m | 0% | 0.27% | |||
18,000 | JP¥11.7m | 0% | no data | |||
1,200 | JP¥778.1k | 0% | no data | |||
1,000 | JP¥649.2k | 0% | no data | |||
600 | JP¥389.9k | 0% | no data |